Free Trial
NASDAQ:JMAC

Maxpro Capital Acquisition (JMAC) Stock Price, News & Analysis

Maxpro Capital Acquisition logo
$10.81
-0.71 (-6.16%)
(As of 03/29/2023)

About Maxpro Capital Acquisition Stock (NASDAQ:JMAC)

Key Stats

Today's Range
$10.08
$12.72
50-Day Range
$0.11
$10.81
52-Week Range
$7.50
$19.22
Volume
119,000 shs
Average Volume
74,040 shs
Market Capitalization
$145.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Maxpro Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Taipei City, Taiwan.

Receive JMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maxpro Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter.

JMAC Stock News Headlines

CRUSHED: How Biden's Replacement Will Devastate Your 401(k)!
Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.
Maxpro Capital Acquisition Corp
See More Headlines

JMAC Stock Analysis - Frequently Asked Questions

Maxpro Capital Acquisition's stock was trading at $0.9650 at the start of the year. Since then, JMAC stock has increased by 1,020.2% and is now trading at $10.81.
View the best growth stocks for 2024 here
.

Shares of JMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Maxpro Capital Acquisition investors own include Meta Platforms (META), PhaseBio Pharmaceuticals (PHAS), Dermata Therapeutics (DRMA), Daifuku (DAIUF), CXApp (CXAI), Centogene (CNTG) and China Jo-Jo Drugstores (CJJD).

Company Calendar

Today
11/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:JMAC
Web
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
10,840,000
Market Cap
$145.16 million
Optionable
Not Optionable
Beta
0.01
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NASDAQ:JMAC) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners